Live Analyst Rating Changes 24938 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Brett Fishbin
KEY

Brett Fishbin

KeyBanc
Wall Street Analyst
★★★★☆
#329
on 13Foresight · ranked by our own returns
77%
Success Rate
+9.6%
Average Return
17 of 22 calls profitable · +3.3% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 77% of Brett Fishbin's ratings turned a profit when each position was held for 1 year — averaging +9.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

29 Buy 15 Hold 0 Sell
Brett's Stock Coverage 13 ratings · 2026-08-14
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
RMD
Resmed
 Aug 07, 2026 BUY Buy
+1.2% avg upside
27 analysts
$255.00
12.42% Upside
 +6.6% ·
SOLV
Solventum Corporation
 Aug 06, 2026 BUY Buy
+5.8% avg upside
16 analysts
$102.00
18.00% Upside
 +6.8% ·
LMAT
Lemaitre Vascular
 Aug 05, 2026 HOLD Strong Buy
+22.1% avg upside
15 analysts
 — +4.3% ·
INSP
Inspire Medical Systems
 Aug 04, 2026 HOLD Buy
+45.8% avg upside
21 analysts
 — -11.0% ·
ITGR
Integer Holdings
 Aug 03, 2026 HOLD Buy
-18.1% avg upside
16 analysts
 — +0.7% ·
KE
Kimball Electronics
 Jul 02, 2026 HOLD Buy
+14.1% avg upside
7 analysts
 — +0.4% ·
LIVN
LivaNova
 Jun 22, 2026 BUY Strong Buy
-0.9% avg upside
15 analysts
$92.00
11.87% Upside
 +4.5% ·
CH:ALC
Alcon
 Jun 12, 2026 BUY Strong Buy
+19.2% avg upside
35 analysts
$71.24
17.16% Upside
 +6.7% ·
COO
Cooper Co
 Jun 05, 2026 HOLD Buy
+74.2% avg upside
21 analysts
 — +13.9% ·
STE
Steris
 May 13, 2026 BUY Strong Buy
+1.8% avg upside
10 analysts
$269.00
13.99% Upside
 +13.5% ·
ICUI
ICU Medical
 May 08, 2026 BUY Strong Buy
-2.9% avg upside
9 analysts
$164.00
10.38% Downside
 +45.1% ·
SHC
Sotera Health
 Nov 05, 2025 HOLD Strong Buy
+15.9% avg upside
13 analysts
 — +19.5% ·
UFPT
Ufp Technologies
 Jul 01, 2024 HOLD Strong Buy
-41.0% avg upside
7 analysts
 — -12.7% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Brett Fishbin — Frequently Asked Questions
How accurate are Brett Fishbin's stock ratings?
Based on the calls 13Foresight could measure, about 77% of Brett's ratings were profitable over a one-year hold, with an average return of +9.4% per rating, or +3.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Brett ranked on 13Foresight?
Brett Fishbin is currently ranked #329 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Brett cover?
Brett most recently has ratings on RMD, SOLV, LMAT, INSP, ITGR, KE, LIVN, CH:ALC, COO, STE, ICUI, SHC and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.